title: Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
abstract: Acceptable rates of fertilization, implantation, clinical pregnancy, ongoing pregnancy, and early pregnancy loss were achieved in high responders after triggering final oocyte maturation with a combination of leuprolide acetate and hCG (1,000 to 2,500 IU). These findings, along with the absence of ovarian hyperstimulation syndrome, suggest that this dual trigger is safe and effective for oocyte maturation in patients with significant risk factors for ovarian hyperstimulation syndrome.
authors.affiliation: Fertility Center of Las Vegas, 8851 West Sahara Avenue, Suite 100, Las Vegas, Nevada 89117, USA. bsshapiro@aol.com
authors.forename: Bruce S
authors.initials: BS
authors.lastname: Shapiro
authors.forename: Said T
authors.initials: ST
authors.lastname: Daneshmand
authors.forename: Forest C
authors.initials: FC
authors.lastname: Garner
authors.forename: Martha
authors.initials: M
authors.lastname: Aguirre
authors.forename: Shyni
authors.initials: S
authors.lastname: Thomas
mesh_terms: D000022:Abortion, Spontaneous / Q000139:chemically induced / Q000517:prevention & control; D000328:Adult; D006063:Chorionic Gonadotropin / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D010064:Embryo Implantation; D004624:Embryo Transfer; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage* / Q000009:adverse effects; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D006727:Hormone Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007246:Infertility / Q000628:therapy*; D016729:Leuprolide / Q000008:administration & dosage* / Q000009:adverse effects; D054315:Oocyte Retrieval; D016471:Ovarian Hyperstimulation Syndrome / Q000139:chemically induced / Q000517:prevention & control*; D010062:Ovulation Induction / Q000009:adverse effects / Q000379:methods*; D010865:Pilot Projects; D011247:Pregnancy; D018873:Pregnancy Rate; D012189:Retrospective Studies; D020554:Sperm Injections, Intracytoplasmic; D016896:Treatment Outcome
chemical_list: D006063:Chorionic Gonadotropin; D005300:Fertility Agents, Female; D006727:Hormone Antagonists; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide